ACR Highlights… ACR Convergence 2025 Highlights- Vasculitis 24 Nov 2025 MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial Abstract format and assignment number: Oral presentation 0891 Presenting author: M Samson (France) Date: Monday…
ACR Highlights… ACR Convergence 2025 Highlights- Paediatric rheumatology 24 Nov 2025 Efficacy of Tumor Necrosis Factor Inhibitors in Children Diagnosed With Non-Systemic Juvenile Idiopathic Arthritis <2 Years Old Using The Childhood Arthritis and Rheumatology Research Alliance Registry Abstract format and assignment…
ACR Highlights… ACR Convergence 2025 Highlights- Rheumatoid Arthritis 24 Nov 2025 A Phase 1 Study of Autologous CAR-Treg Cells in Refractory Rheumatoid Arthritis: Interim Report of Safety and Efficacy Abstract format and assignment number: Late-breaking abstract LB23 Presenting author: Kohler Minna…
ACR Highlights… ACR Convergence 2025 Highlights- Basic and Translational Research 24 Nov 2025 Longitudinal peripheral blood multi-omic profiling in at-risk individuals uncovers immune signatures and predictive models for future rheumatoid arthritis conversion Abstract format and assignment number: Oral presentation 0774 Presenting author: J.…
ACR Highlights… ACR Convergence 2025 Highlights- Connective Tissue Diseases 24 Nov 2025 Redefining When to Biopsy the Kidney in Patients with SLE Abstract format and assignment number: Oral presentation 0772 Presenting author: M Petri (USA) Date: Sunday 26th October 2025 Lupus nephritis is…
ACR Highlights… ACR Convergence 2025 Highlights- Non inflammatory Rheumatic Diseases (Osteoarthritis, Osteoporosis and Metabolic bone disease, etc.) 24 Nov 2025 Romosozumab as a Safe Bone-Forming Treatment for Elderly Patients with Established Cardiovascular Risk Factors Poster presentation: POS 0341 Date: Sunday, 26th October 2025 Presenting author: D. Ramos Castro (Spain) This…
ACR Highlights… ACR Convergence 2025 Highlights- Other inflammatory arthritides (such as CPPD and gout) and autoinflammatory diseases 24 Nov 2025 Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI) Abstract format and assignment number: Oral presentation 0777 Date: Sunday, 26th October 2025 Presenting author: M. Koster…
EULAR 2025 highlights… EULAR 2025 Highlights- Rheumatoid Arthritis: Clinical (non-therapeutic) 18 Jul 202518 Jul 2025 Trends in Incidence and Predictors of Incident Venous Thromboembolism in Patients with Rheumatoid Arthritis: A Population-Based Retrospective Cohort Study Abstract format and assignment number: Oral presentation OP0070 Presenting author: E…
EULAR 2025 highlights… EULAR 2025 Highlights – Rare and Autoinflammatory diseases 18 Jul 202518 Jul 2025 A WINDOW OF OPPORTUNITY IN STILL’S DISEASE: THE EARLY INTRODUCTION OF IL-1 INHIBITORS FOR ACHIEVING CLINICAL INACTIVE DISEASE Abstract format and assignment number: Poster 0377 Presenting author: S. Bindoli (Italy)…
ACR Highlights… ACR Convergence 2024 Highlights- Rheumatoid Arthritis: Clinical (non-therapeutic) 19 Dec 202419 Dec 2024 Fracture Incidence Rates in Persons with Rheumatoid Arthritis by Disease Activity Level Abstract format and assignment number: Oral presentation 1748 Presenting author: R. Elam (United States) Date: Sunday, 17th November 2024 In…